SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000919574-22-001951
Filing Date
2022-02-25
Accepted
2022-02-25 17:02:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 d9375508_13g-a.htm SC 13G/A 119172
  Complete submission text file 0000919574-22-001951.txt   120694
Mailing Address 500 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 500 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 212-848-0519
SAMLYN CAPITAL, LLC (Filed by) CIK: 0001421097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Subject) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91126 | Film No.: 22681604
SIC: 2834 Pharmaceutical Preparations